Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.5.1961

PKM2 Regulates Hepatocellular Carcinoma Cell Epithelial-mesenchymal Transition and Migration upon EGFR Activation  

Fan, Fang-Tian (Department of Pharmacology, College of Pharmacy, Nanjing University of Chinese Medicine)
Shen, Cun-Si (Department of Pharmacology, College of Pharmacy, Nanjing University of Chinese Medicine)
Tao, Li (Department of Pharmacology, College of Pharmacy, Nanjing University of Chinese Medicine)
Tian, Chao (Department of Pharmacology, College of Pharmacy, Nanjing University of Chinese Medicine)
Liu, Zhao-Guo (Department of Pharmacology, College of Pharmacy, Nanjing University of Chinese Medicine)
Zhu, Zhi-Jie (Department of Pharmacology, College of Pharmacy, Nanjing University of Chinese Medicine)
Liu, Yu-Ping (Department of Pharmacology, College of Pharmacy, Nanjing University of Chinese Medicine)
Pei, Chang-Song (Department of Pharmacology, College of Pharmacy, Nanjing University of Chinese Medicine)
Wu, Hong-Yan (Department of Pharmacology, College of Pharmacy, Nanjing University of Chinese Medicine)
Zhang, Lei (Department of Pharmacology, College of Pharmacy, Nanjing University of Chinese Medicine)
Wang, Ai-Yun (Department of Pharmacology, College of Pharmacy, Nanjing University of Chinese Medicine)
Zheng, Shi-Zhong (Department of Pharmacology, College of Pharmacy, Nanjing University of Chinese Medicine)
Huang, Shi-Le (Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center Shreveport)
Lu, Yin (Department of Pharmacology, College of Pharmacy, Nanjing University of Chinese Medicine)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.5, 2014 , pp. 1961-1970 More about this Journal
Abstract
Pyruvate kinase isozyme type M2 (PKM2) was first found in hepatocellular carcinoma (HCC), and its expression has been thought to correlate with prognosis. A large number of studies have demonstrated that epithelial-mesenchymal transition (EMT) is a crucial event in hepatocellular carcinoma (HCC) and associated metastasis, resulting in enhanced malignancy of HCC. However, the roles of PKM2 in HCC EMT and metastasis remain largely unknown. The present study aimed to determine the effects of PKM2 in EGF-induced HCC EMT and elucidate the molecular mechanisms in vitro. Our results showed that EGF promoted EMT in HCC cell lines as evidenced by altered morphology, expression of EMT-associated markers, and enhanced invasion capacity. Furthermore, the present study also revealed that nuclear translocation of PKM2, which is regulated by the ERK pathway, regulated ${\beta}$-catenin-TCF/LEF-1 transcriptional activity and associated EMT in HCC cell lines. These discoveries provide evidence of novel roles of PKM2 in the progression of HCC and potential therapeutic target for advanced cases.
Keywords
Epithelial growth factor receptor; PKM2; ${\beta}$-catenin; epithelial-mesenchymal transition; HCC;
Citations & Related Records
Times Cited By KSCI : 6  (Citation Analysis)
연도 인용수 순위
1 Yang W, Zheng Y, Xia Y, et al (2012). ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol, 14, 1295-304.   DOI   ScienceOn
2 Wong N, De Melo J, Tang D (2013). PKM2, a Central Point of Regulation in Cancer Metabolism. Int J Cell Biol, 2013, 242513.
3 Xu Z, Shen MX, Ma DZ, et al (2003). TGF-beta1-promoted epithelial-to-mesenchymal transformation and cell adhesion contribute to TGF-beta1-enhanced cell migration in SMMC-7721 cells. Cell Res, 13, 343-50.   DOI   ScienceOn
4 Yang W, Xia Y, Ji H, et al (2011). Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature, 480, 118-22.
5 Zhang Q, Bai X, Chen W, et al (2013). Wnt/beta-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1alpha signaling. Carcinogenesis.???
6 Zhou CF, Li XB, Sun H, et al (2012a). Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells. IUBMB Life, 64, 775-82.   DOI
7 Zhou L, Liu C, Meng FD, et al (2012b). Long-term prognosis in hepatocellular carcinoma patients after hepatectomy. Asian Pac J Cancer Prev, 13, 483-6.   과학기술학회마을   DOI   ScienceOn
8 Zhu WJ, Huang CY, Li C, et al (2013). Risk factors for early recurrence of hbv-related hepatocellular carcinoma meeting milan criteria after curative resection. Asian Pac J Cancer Prev, 14, 7101-6.   과학기술학회마을   DOI   ScienceOn
9 Spoden GA, Rostek U, Lechner S, et al (2009). Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply. Exp Cell Res, 315, 2765-74.   DOI   ScienceOn
10 Ogunwobi OO, Liu C (2011). Hepatocyte growth factor upregulation promotes carcinogenesis and epithelialmesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways. Clin Exp Metastasis, 28, 721-31.   DOI
11 Pan FY, Zhang SZ, Xu N, et al (2010). Beta-catenin signaling involves HGF-enhanced HepG2 scattering through activating MMP-7 transcription. Histochem Cell Biol, 134, 285-95.   DOI
12 Personeni N, Rimassa L, Santoro A (2012). Biomarkers in hepatocellular carcinoma--letter. Clin Cancer Res, 18, 4861.   DOI   ScienceOn
13 Tamada M, Suematsu M, Saya H (2012). Pyruvate kinase m2: multiple faces for conferring benefits on cancer cells. Clin Cancer Res, 18, 5554-61.   DOI   ScienceOn
14 Tan X, Apte U, Micsenyi A, et al (2005). Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. Gastroenterology, 129, 285-302.   DOI   ScienceOn
15 Tanaka M, Masaki Y, Tanaka K, et al (2013). Reduction of fatty acid oxidation and responses to hypoxia correlate with the progression of de-differentiation in HCC. Mol Med Rep, 7, 365-70.
16 Tsuji T, Ibaragi S, Hu GF (2009). Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res, 69, 7135-9.   DOI   ScienceOn
17 Wang LY, Liu YP, Chen LG, et al (2013). Pyruvate kinase M2 plays a dual role on regulation of the EGF/EGFR signaling via E-cadherin-dependent manner in gastric cancer cells. PLoS One, 8, e67542.   DOI
18 Liu D, Aguirre Ghiso J, Estrada Y, Ossowski L (2002). EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell, 1, 445-57.   DOI   ScienceOn
19 Wiangnon S, Kamsa-ard S, Suwanrungruang K, et al (2012). Trends in incidence of hepatocellular carcinoma, 1990-2009, Khon Kaen, Thailand. Asian Pac J Cancer Prev, 13, 1065-8.   과학기술학회마을   DOI   ScienceOn
20 Luo W, Hu H, Chang R, et al (2011a). Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell, 145, 732-44.   DOI   ScienceOn
21 Llovet JM, Bruix J (2008). Molecular targeted therapies in hepatocellular carcinoma. Hepatology, 48, 1312-27.   DOI   ScienceOn
22 Lu Z, Ghosh S, Wang Z, Hunter T (2003). Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell, 4, 499-515.   DOI   ScienceOn
23 Luo W, Semenza GL (2011b). Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells. Oncotarget, 2, 551-6.
24 Macintyre AN, Rathmell JC (2011). PKM2 and the tricky balance of growth and energy in cancer. Mol Cell, 42, 713-4.   DOI   ScienceOn
25 Maheswaran T, Rushbrook SM (2012). Epithelial-mesenchymal transition and the liver: role in hepatocellular carcinoma and liver fibrosis. J Gastroenterol Hepatol, 27, 418-20.   DOI   ScienceOn
26 Mittal S, El-Serag HB (2013). Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol, 47 Suppl, S2-6.   DOI
27 Fang D, Hawke D, Zheng Y, et al (2007). Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol Chem, 282, 11221-9.   DOI   ScienceOn
28 Nejak-Bowen KN, Monga SP (2011). Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol, 21, 44-58.   DOI   ScienceOn
29 Norsa'adah B, Nurhazalini-Zayani CG (2013). Epidemiology and survival of hepatocellular carcinoma in north-east Peninsular Malaysia. Asian Pac J Cancer Prev, 14, 6955-9.   과학기술학회마을   DOI   ScienceOn
30 Eggert T, McGlynn KA, Duffy A, et al (2013). Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000-10. Gut.
31 Fischer AN, Fuchs E, Mikula M, et al (2007). PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. Oncogene, 26, 3395-405.   DOI   ScienceOn
32 Guan CN, Chen XM, Lou HQ, et al (2012). Clinical significance of axin and beta-catenin protein expression in primary hepatocellular carcinomas. Asian Pac J Cancer Prev, 13, 677-81.   과학기술학회마을   DOI   ScienceOn
33 Guarino M (2007). Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol, 39, 2153-60.   DOI   ScienceOn
34 Hu T, Li C (2010). Convergence between Wnt-beta-catenin and EGFR signaling in cancer. Mol Cancer, 9, 236.
35 Ji H, Wang J, Nika H, et al (2009). EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-catenin from beta-catenin and transactivation of beta-catenin. Mol Cell, 36, 547-59.   DOI   ScienceOn
36 Al Moustafa AE, Achkhar A, Yasmeen A (2012). EGF-receptor signaling and epithelial-mesenchymal transition in human carcinomas. Front Biosci (Schol Ed), 4, 671-84.
37 Lee J, Kim HK, Han YM, Kim J (2008). Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription. Int J Biochem Cell Biol, 40, 1043-54.   DOI   ScienceOn
38 Li SH, Guo ZX, Xiao CZ, et al (2013). Risk factors for early and late intrahepatic recurrence in patients with single hepatocellular carcinoma without macrovascular invasion after curative resection. Asian Pac J Cancer Prev, 14, 4759-63.   과학기술학회마을   DOI   ScienceOn
39 Cano A, Perez-Moreno MA, Rodrigo I, et al (2000). The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol, 2, 76-83.   DOI   ScienceOn
40 Altekruse SF, McGlynn KA, Dickie LA, Kleiner DE (2012). Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008. Hepatology, 55, 476-82.   DOI   ScienceOn
41 Buckley AF, Burgart LJ, Sahai V, Kakar S (2008). Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma. Am J Clin Pathol, 129, 245-51.   DOI   ScienceOn
42 Eastham AM, Spencer H, Soncin F, et al (2007). Epithelialmesenchymal transition events during human embryonic stem cell differentiation. Cancer Res, 67, 11254-62.   DOI   ScienceOn
43 Gao X, Wang H, Yang JJ, et al (2012). Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell, 45, 598-609.   DOI   ScienceOn